Herniariae herba
Table of contents
Overview
This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of rupturewort. The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing rupturewort.
This summary is not intended to provide practical advice on how to use medicines containing rupturewort. For practical information about using rupturewort medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Key facts
Latin name | Herniariae herba |
English common name | Rupturewort |
Botanical name | Herniaria glabra L.; Herniaria hirsuta L.; Herniaria incana Lam. |
Therapeutic area |
Urinary tract and genital disorders
|
Status |
F: Assessment finalised
|
Date added to the inventory |
30/01/2018
|
Date added to priority list |
30/01/2018
|
Outcome of European assessment |
European Union herbal monograph
|
Documents
-
List item
Draft European Union herbal monograph on Herniaria glabra L., H. hirsuta L., H. incana Lam., herba (PDF/124.16 KB)
Draft: consultation closed
First published: 19/12/2019
Consultation dates: 19/12/2019 to 15/03/2020
EMA/HMPC/554043/2018 -
List item
Draft assessment report on Herniariae glabra L.; Herniariae hirsuta L.; Herniariae incana LAM., herba (PDF/240.27 KB)
Draft
First published: 19/12/2019
EMA/HMPC/554033/2018 -
List item
Draft list of references supporting the assessment of Herniaria glabra L., H. hirsuta L., H. incana Lam., herba (PDF/105.94 KB)
Draft
First published: 19/12/2019
EMA/HMPC/554034/2018 -
List item
Call for scientific data for use in HMPC assessment work on Herniariae glabra L.; Herniariae hirsuta L.; Herniariae incana LAM., herba (PDF/75.44 KB)
Draft: consultation closed
First published: 28/03/2018
Last updated: 28/03/2018
Consultation dates: 31/03/2018 to 30/06/2018
EMA/HMPC/1887935/2018